Sai-Hong Ignatius Ou, MD, PhD, University of California, Irvine School of Medicine

Dr Liu Previews ASCO 2024 Lung Cancer Data

Dr Rajkumar Previews ASCO 2024 Data in Multiple Myeloma

Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer

Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer